Consolidated Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7351594

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Consolidated statement of income
Statement of income
Net sales
87,267,000,000 JPY
80,707,000,000 JPY
Ordinary income
Other operating income
Share of profit of entities accounted for using equity method
4,000,000 JPY
JPY
Operating expenses
Selling, general and administrative expenses
33,848,000,000 JPY
32,352,000,000 JPY
Operating expenses
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
JPY
5,000,000 JPY
Cost of sales
48,953,000,000 JPY
43,652,000,000 JPY
Net sales
Gross profit (loss)
38,314,000,000 JPY
37,055,000,000 JPY
Operating profit (loss)
4,465,000,000 JPY
4,702,000,000 JPY
Ordinary profit (loss)
5,053,000,000 JPY
5,336,000,000 JPY
Operating expenses
Research and development expenses
5,710,000,000 JPY
7,156,000,000 JPY
Non-operating income
Interest income
34,000,000 JPY
6,000,000 JPY
Dividend income
459,000,000 JPY
449,000,000 JPY
Other
94,000,000 JPY
143,000,000 JPY
Non-operating income
661,000,000 JPY
712,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Extraordinary income
991,000,000 JPY
1,332,000,000 JPY
Non-operating expenses
Interest expenses
49,000,000 JPY
50,000,000 JPY
Other
17,000,000 JPY
20,000,000 JPY
Non-operating expenses
73,000,000 JPY
78,000,000 JPY
Extraordinary losses
895,000,000 JPY
707,000,000 JPY
Impairment losses
JPY
105,000,000 JPY
Profit (loss) before income taxes
5,150,000,000 JPY
5,961,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of non-current assets
0 JPY
4,000,000 JPY
Gain on sale of investment securities
991,000,000 JPY
45,000,000 JPY
Extraordinary losses
Loss on sale of investment securities
JPY
1,000,000 JPY
Income taxes
1,235,000,000 JPY
1,583,000,000 JPY
Profit (loss)
3,914,000,000 JPY
4,377,000,000 JPY
Profit (loss) attributable to owners of parent
3,914,000,000 JPY
4,377,000,000 JPY
Profit attributable to
Other comprehensive income
Valuation difference on available-for-sale securities
-448,000,000 JPY
347,000,000 JPY
Foreign currency translation adjustment
46,000,000 JPY
303,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
16,000,000 JPY
-3,000,000 JPY
Remeasurements of defined benefit plans, net of tax
293,000,000 JPY
274,000,000 JPY
Other comprehensive income
-92,000,000 JPY
922,000,000 JPY
Comprehensive income
3,821,000,000 JPY
5,300,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,821,000,000 JPY
5,300,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.